Spectral AI, Inc. (MDAI) Stock Price, Financials & Summary

Price chart

Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18

Key dataSep 18, 2026

Open$1.62

From 52W high−38.81%

Volume220924.00

Market cap$52.78M

P/E (TTM)—

P/S (TTM)3.5x

Div yield—

Key dataSep 18, 2026

Open

$1.62

From 52W high

−38.81%

Volume

220924.00

Market cap

$52.78M

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−6.5x

P/E (TTM)

—

RSI (14)

50.2

MomentumView details →

1D Return

+3.14%

YTD Return

+13.03%

SummaryUpdated Jun 1, 2026

Spectral AI, Inc. (NASDAQ:MDAI) is a Dallas-based artificial intelligence company founded to revolutionize medical diagnostics in wound care. The company went public in April 2021 and has since focused on developing AI-powered diagnostic tools that help healthcare providers make faster and more accurate treatment decisions for patients with burns and diabetic foot ulcers. Spectral AI's flagship product, the DeepView system, represents a significant advancement in wound assessment technology, offering objective analysis capabilities that often surpass traditional clinical judgment.

Ask drillr about Spectral AI, Inc. →

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

−6.5x

EV/Sales

3.6x

P/S (TTM)

3.5x

P/B (TTM)

−4.4x

ProfitabilityView details →

Gross Margin

41.51%

Net Margin

−69.27%

EBITDA Margin

−55.87%

ROE (TTM)

87.09%

ROA (TTM)

−54.01%

Asset Turnover

0.82x

GrowthView details →

Revenue YoY

−44.99%

EPS YoY

+48.26%

FCF YoY

—

Revenue CAGR 3Y

−8.16%

EPS CAGR 3Y

+65.88%

EBITDA YoY

+26.96%

MomentumView details →

1D Return

+3.14%

YTD Return

+13.03%

1Y Return

−33.40%

RSI (14)

50.2

vs 50D SMA

−1.03%

vs 200D SMA

−5.49%

Capital & dividendView details →

Debt/Equity

−1.35x

Current Ratio

0.90x

Quick Ratio

0.85x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−$0.13

EPS Surprise

3.70%

Beats (12Q)

3/12

Next Q EPS Est

−$0.14

Avg Surprise (4Q)

−7.71%

Rev Surprise

−15.45%

Financials snapshotView financials →

Revenue (TTM)

15.16M

Net Income (TTM)

−10.50M

Op. CF (TTM)

−12.88M

Next earningsNov 10, 2026 →

Latest newsMore news →

Spectral AI, Inc. announced its financial results for the second quarter ended June 30, 2026, reporting a strong cash position of $14.0 million.40d ago

Similar companies

Envoy Medical, Inc.COCH TELA Bio, Inc.TELA Sensus Healthcare, Inc.SRTS Rapid Micro Biosystems, Inc.RPID Nano-X Imaging Ltd.NNOX Outset Medical, Inc.OM Find similar companies →

Latest newsMore news →

Spectral AI, Inc. announced its financial results for the second quarter ended June 30, 2026, reporting a strong cash position of $14.0 million.40d ago